id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-305304-d3x734nu	Birnbaum, Yochai	Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?	2020-07-15		.txt	text/plain	3726	193	42	The following studies provide evidence that underpins the current guideline recommendations for treatment of inferior STEMI: Several randomized trials have compared outcomes of fibrinolytic therapy vs. The Intravenous Streptokinase in Acute Myocardial Infarction (ISAM) trial [8] , the APSAC Intervention Mortality Study (AIMS) [9] , the Anglo-Scandinavian Study of Early Thrombolysis (ASSET) trial [10] , the Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur (EMERAS) trial [11] , and the Late Assessment of Thrombolytic Efficacy (LATE) study [12] did not report on patient subgroup analysis based on infarct location or on concomitant use of other medications so the value of the use of fibrinolytic therapy in inferior STEMI cannot be ascertained. The Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI), on the other hand, did report the advantage of pPCI over fibrinolytic therapy in patients with inferior STEMI [30] .	./cache/cord-305304-d3x734nu.txt	./txt/cord-305304-d3x734nu.txt